{"id":"W4281747213","doi":"10.1200/jco.2022.40.16_suppl.11563","title":"Phase 1b study of weekly split-dose selinexor in soft tissue sarcoma (STS).","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Tolerability; Clinical endpoint; Adverse effect; Regimen; Internal medicine; Common Terminology Criteria for Adverse Events; Phases of clinical research; Toxicity; Dosing; Clinical trial; Oncology; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001150307,0.001216502,0.001593688,0.0006765827,0.0003013283,0.0006485661,0.0006495091,0.0009954505,0.00694516],"category_scores_gemma":[0.0005604645,0.0005609644,0.0008154475,0.0004720004,0.0006523041,0.0006455877,0.0003978024,0.002521341,0.001669448],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000521647,"about_ca_system_score_gemma":0.001183499,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00057569,"about_ca_topic_score_gemma":0.001414418,"domain_scores_codex":[0.9997285,0.0001072051,0.00001674523,0.00005194189,0.00003916979,0.00005631178],"domain_scores_gemma":[0.9995583,0.00006101686,0.0000851777,0.00004422241,0.00003309476,0.0002181263],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4665684,0.1802073,0.007273037,0.001625611,0.001199931,0.0004223785,0.0004886328,0.006076534,0.1832391,0.000488909,0.005163687,0.1472464],"study_design_scores_gemma":[0.2700586,0.7018051,0.01439211,0.00004220742,0.0002422847,0.0004431345,0.00007330833,0.001673598,0.007585619,0.0001977493,0.003462408,0.000023864],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9908978,0.001151033,0.0007993322,0.0002455664,0.00006779694,0.003696644,0.001522843,0.0001077362,0.001511116],"genre_scores_gemma":[0.9832852,0.001505369,0.002026832,0.0005293099,0.00006921151,0.003673763,0.003835743,0.00004071856,0.00503392],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00694516,"threshold_uncertainty_score":0.02323389,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1631333716355005,"score_gpt":0.5203821345055201,"score_spread":0.3572487628700196,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}